Latest filing: Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Gufic Biosciences Limited
ObservedCompany dossier
Gufic BioSciences
NSE:GUFICBIO · ISIN INE742B01025
- Close
- ₹382.35 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Gufic BioSciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹207.8 Cr · PAT ₹19.3 Cr.
Exchange XBRLLatest ownership: promoter group 72.50% and public 27.50% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Gufic Biosciences Limited
NSE · exchange filing
Observed
Source filing Gufic Biosciences Ltd - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Copy of Newspaper Publication - Gufic Biosciences Limited
NSE · exchange filing
Observed
Source filing Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹207.8 Cr
- Profit after tax
- ₹19.3 Cr
- EPS
- ₹1.93
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 72.50%
- Public
- 27.50%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL